CD4 and neoplasm: However, we did not distinguish among CD4+ T cell subsets—such as Th1, Th2, Th17, or FOXP3+ regulatory T cells (Tregs)—each of which can exert distinct and sometimes opposing immunologic effects within the tumor microenvironment [55].